Digirad Co. (NASDAQ:DRAD) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 145,100 shares, a growth of 9.3% from the January 15th total of 132,700 shares. Currently, 7.8% of the shares of the company are sold short. Based on an average trading volume of 34,000 shares, the days-to-cover ratio is currently 4.3 days.
DRAD traded down $0.09 during trading on Friday, hitting $2.92. The stock had a trading volume of 635 shares, compared to its average volume of 44,260. The firm has a market cap of $6.58 million, a PE ratio of -1.01 and a beta of 2.21. Digirad has a 12 month low of $2.46 and a 12 month high of $11.40. The company has a current ratio of 1.08, a quick ratio of 0.77 and a debt-to-equity ratio of 1.04. The company has a 50 day simple moving average of $2.94 and a 200-day simple moving average of $3.84.
Digirad (NASDAQ:DRAD) last announced its earnings results on Thursday, November 14th. The medical equipment provider reported $0.01 EPS for the quarter. Digirad had a negative net margin of 5.74% and a negative return on equity of 8.92%. The firm had revenue of $28.33 million for the quarter.
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Further Reading: Correction
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.